Pioglitazone

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Peritoneal Dialysis

Conditions

Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, Inflammation

Trial Timeline

Jan 1, 2008 โ†’ Sep 1, 2008

About Pioglitazone

Pioglitazone is a pre-clinical stage product being developed by Baxter for Peritoneal Dialysis. The current trial status is completed. This product is registered under clinical trial identifier NCT01258322. Target conditions include Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT01258322Pre-clinicalCompleted

Competing Products

20 competing products in Peritoneal Dialysis

See all competitors